What does it mean that a tumor sample has a mutation or rearrangement? Exactly what is being measured? Is the presence of a mutation on an NGS panel an

What does it mean that a tumor sample has a mutation or rearrangement? Exactly what is being measured? Is the presence of a mutation on an NGS panel an "all-or-none" phenomenon?

Exactly what does it mean that a tumor sample has a mutation or rearrangement? Exactly what is being measured? Is the presence of a mutation on an NGS panel an “all-or–none” phenomenon or are there additional quantitative levels of characterization available once a genomic alteration is identified?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Lynn Wang, MD, PhD, FCAP

Professor Lynn Wang, MD, PhD, FCAP

Professor, Division of Genomic and Molecular Pathology
Founding Medical Director
Genomic and Molecular Pathology
University of Chicago Medical Center
Chicago, IL, USA